Vanguard Fiduciary Trust
DMAC icon

Vanguard Fiduciary Trust’s DiaMedica Therapeutics DMAC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
207,438
+19,714
+11% +$121K ﹤0.01% 2843
2026
Q1 		$1.27M Buy
+187,724
New +$1.49M ﹤0.01% 2807

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Fiduciary Trust's DMAC Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its DiaMedica Therapeutics (DMAC) stake by 11% in Q2 2026, buying an estimated $121K and bringing the position to 207,438 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

Vanguard Fiduciary Trust first reported a position in DMAC in Q1 2026 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Vanguard Fiduciary Trust held 207,438 shares of DiaMedica Therapeutics worth $1.46M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 19,714 DiaMedica Therapeutics shares in Q2 2026, an estimated $121K.
  • DiaMedica Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2843 holding.
  • Vanguard Fiduciary Trust first reported a position in DiaMedica Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.